Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe webpage has undergone significant updates, including the introduction of new treatment arms involving Pembrolizumab combined with specific chemotherapy regimens, and the removal of previous treatment arm references. Additionally, new metrics for evaluating treatment outcomes, such as Event-free Survival and Overall Survival, have been added.SummaryDifference6%
- Check43 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
- Check50 days agoChange DetectedThe website has updated to version v2.14.2, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.14.1.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check73 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check102 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.